What is he best known for?
The fields of study he is best known for:
- Bacteria
- Antibiotics
- Gene
Vincent Perreten focuses on Microbiology, Genetics, Antibiotic resistance, SCCmec and Plasmid.
Vincent Perreten has included themes like Staphylococcus pseudintermedius, Staphylococcus, Staphylococcus aureus and Escherichia coli in his Microbiology study.
His Antibiotic resistance research is multidisciplinary, incorporating elements of Tetracycline, Staphylococcus haemolyticus and Raw milk.
His studies deal with areas such as Mupirocin and Staphylococcus xylosus as well as SCCmec.
His work focuses on many connections between Plasmid and other disciplines, such as Enterococcus faecalis, that overlap with his field of interest in Antibacterial agent, Major facilitator superfamily, Efflux and Enterococcus faecium.
His biological study spans a wide range of topics, including Bacteria and Trimethoprim.
His most cited work include:
- Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study (339 citations)
- Microarray-Based Detection of 90 Antibiotic Resistance Genes of Gram-Positive Bacteria (235 citations)
- Antibiotic resistance spread in food (226 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Microbiology, Antibiotic resistance, Genetics, Gene and Escherichia coli.
Vincent Perreten works in the field of Microbiology, focusing on Antibiotics in particular.
His research investigates the link between Antibiotic resistance and topics such as Tetracycline that cross with problems in Ampicillin.
His Escherichia coli study combines topics in areas such as Mutant and Cephalosporin.
Vincent Perreten combines subjects such as Enterococcus faecalis and Virulence with his study of Plasmid.
His work deals with themes such as Staphylococcus pseudintermedius and Antimicrobial, which intersect with SCCmec.
He most often published in these fields:
- Microbiology (68.69%)
- Antibiotic resistance (27.78%)
- Genetics (24.24%)
What were the highlights of his more recent work (between 2018-2021)?
- Microbiology (68.69%)
- Escherichia coli (15.66%)
- Antibiotic resistance (27.78%)
In recent papers he was focusing on the following fields of study:
Vincent Perreten mainly focuses on Microbiology, Escherichia coli, Antibiotic resistance, Multiple drug resistance and Plasmid.
His work on Colistin as part of general Microbiology research is frequently linked to Strain, bridging the gap between disciplines.
His Escherichia coli research includes elements of Kanamycin, Genotyping and Trimethoprim.
His Antibiotic resistance research incorporates elements of Tetracycline, Infection control and Acinetobacter.
His Plasmid study combines topics from a wide range of disciplines, such as Whole genome sequencing and Virulence.
His research on Gene concerns the broader Genetics.
Between 2018 and 2021, his most popular works were:
- Acinetobacter in veterinary medicine, with an emphasis on Acinetobacter baumannii. (23 citations)
- Acinetobacter in Veterinary Medicine with emphasis on A. baumannii (20 citations)
- Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018. (14 citations)
In his most recent research, the most cited papers focused on:
- Bacteria
- Antibiotics
- Gene
His primary areas of investigation include Antibiotic resistance, Microbiology, Escherichia coli, Plasmid and Multiple drug resistance.
Vincent Perreten interconnects Internal medicine, Intensive care, Infection control and Acinetobacter in the investigation of issues within Antibiotic resistance.
His Infection control research is multidisciplinary, incorporating perspectives in Moraxellaceae, Acinetobacter baumannii, Pneumonia, Veterinary medicine and Multilocus sequence typing.
His Escherichia coli study incorporates themes from Kanamycin and Veterinary clinics.
His Plasmid research is classified as research in Genetics.
His research integrates issues of Tetracycline and SCCmec in his study of Multiple drug resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
